Polymerase chain reaction with two molecular targets in mucosal leishmaniasis' diagnosis: A validation study

Memorias do Instituto Oswaldo Cruz

Volumn 102, Issue 5, 2007, Pages 549-554

  Bracho, Clemencia Ovalle ^a   De Quintana, Luisa Porras ^a   Arenas, Sandra Muvdi ^a   Parra, Melania Rios ^a  

^a National Institute of Cancer   (Colombia)

Author keywords

Diagnosis; Leishmaniasis mucocutaneous; Polymerase chain reaction; Ribosomal spacer

Indexed keywords

EID: 34548439943     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762007005000061     Document Type: Article

References (26)

1. Aronson N, Glenn W, Johnson S, Jackson J, Gasser R, Magill A 1998. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis 27: 1457-1464.
2. Bensoussan E, Nasereddin A, Jonas F, Schnur L, Jaffe L 2006. Comparison of PCR assays for diagnosis of cutaneous leishmaniasis. J Clin Microbiol 40: 1435-1439.
3. Chulay D, Effrey J, Spencer HC, Mugamei M 1985. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am J Trop Med Hyg 34: 702-709.
4. Cupolillo E, Grimaldi Jr G, Momen H, Beverley S 1995. Intergenic region typing (IRT): a rapid molecular approach to the characterization and evolution of Leishmania. Mol Bioch Parasitol 73: 145-155.
5. Disch J, Junqueira M, Orsini M, Pirmez C, Oliveira AC, Castro M, Rabello 2005. Leishmania (Viannia) subgenus kDNA amplification for the diagnosis of mucosal leishmaniasis. Diag Microbiol infect Dis 51: 185-190.
6. Hepburn NC, Siddique I, Howie AF, Beckett GJ, Hayes PC 1994. Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 88: 453-455.
7. Instituto Nacional de Salud 2006. Informe de enfermedades transmitidas por vectores (ETV). Inf Quinc Epidem Nac 11: 40-44.
8. Isaza DM, Arboleda M, Restrepo M, McCann SHE, Barker DC 2002. Validation of the polymerase chain reaction for the diagnosis of human cutaneous leishmaniasis in north-west Colombia. Trans R Soc Trop Med Hyg 96: 165-168.
9. Lijmer J, Mol BW, Heisterkamp S, Bonsel G, Prins MH, van der Meulen JHP 1999. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282: 1062-1066.
10. Marsden PD 1985. Clinical presentations of Leishmania braziliensis braziliensis. Parasitol Today 1: 129-133.
11. Medeiros A, Rodrigues S, Roselino A 2002. Comparison of the specificity of PCR and the histopathological detection of Leishmania for the diagnosis of American cutaneous leishmaniasis. Braz J Med Biol Res 35: 421-424.
12. Marfurt J, Nasereddin A, Niederwieser I, Jaffe CL, Beck H-P, Felger I 2003. Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis. J Clin Microbiol 41: 3147-3153.
13. Oddone R, Arbo C, Nara E, Velázquez GR, Acosta ME, Poletti D 2004. Utilidad diagnóstica de los métodos laboratoriales en leishmaniasis mucosa, incluyendo la "PCR". Noticias Técnicas del Laboratorio 4: 7-9.
14. Oliveira JG, Novail OF, Oliveira CI, Cruz JA, Campos FL, Rocjha A, Boaventura V, Noroña A, Jackson, ML Jackson, Barral A 2005. Polymerase chain reaction (PCR) is highly sensible for diagnosis of mucosal leishmaniasis. Acta Trop 94: 55-59.
15. Pappas Michael G, McGreevy PB, Hajkowski R 1983. Evaluation of promastigote and amastigote antigens in the indirect fluorescent antibody test for American cutaneous leishmaniasis. Am J Trop Med Hyg 32: 1260-1267.
16. Pattyn S, Ursi D, Ieven M, Grillone S, Raes V 1993. Detection of Mycobacterium leprae by the polymerase chain reaction in nasal swabs of leprosy patients and their contacts. Int J Lepr 61: 389-393.
17. Pirmez C, Da Silva TV, Oliveira NMP, Da Cruz AM, Gonçalves CSC, Catanho M 1999. Use of PCR in diagnosis of human American tegumentary leishmaniasis in Rio de Janeiro, Brazil. J Clin Microbiol June: 1819-1823.
18. Ridley D, Magalhães A, Marsden P 1989. Histological analysis and the pathogenesis of mucocutaneous leishmaniasis. J Pathol 159: 293-299.
19. Rodgers MR, Popper SJ, Wirth DF1990. Amplification of Kinetoplat ADN as a tool in the detection and diagnosis of Leishmania. Exp Parasitol 71: 267-275.
20. Rodriguez N, Guzman B, Rodas A, Takiff H, Bloom BR, Convit J 1994. Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hibridization. J Clin Microbiol Sep: 2246-2252.
21. Sambrook J 2001. Molecular Cloning A Laboratory Manual. Preparation and Analysis of Eukaryotic Genomic DNA, 3rd ed., Cold Spring Harbor Laboratory Press, New York, p. 6.4-6.12
22. Schonian G, Nasereddin A, Dinse N, Schweynoch C, Schallig H, Presber W 2003. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diag Microbiol and Infect Dis 47: 349-358.
23. Schubach A, Cuzzi-Maya T, Oliveira AV, Sartori A, De Oliveira-Neto MP, Mattos MS 2001. Leishmanial antigens in the diagnosis of active lesions and ancient scars of American tegumentary leishmaniasis patients. Mem Inst Oswaldo Cruz 96: 987-996.
24. Weigle KA, De Davalos M, Heredia P, Molineros R, Saravia NG, D'Alessandro A 1987. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 36: 489-496.
25. WHO-TDR 2005. Surveillance and control of leishmaniasis. http://www.who.int/tdr/diseases/default.htm. Priorities and strategic emphases for TDR supported research on leishmaniasis. http://www.who.int/tdr/disease/ leish/strategy.htm
26. Zajtchuk CJT, Casler JD, Netto EM, Grog M, Neafie RC, Hessel CR 1989. Mucosal leishmaniasis in Brazil. Laryngoscope 99: 925-939